Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 11:16 am Purchase | 2024-09-30 | 13G | Tian Ruixiang Holdings Ltd TIRX | Mitchell P. Kopin | 53,667 2.200% | 0 (+0.00%) | Filing History |
| 2024-11-13 11:15 am Purchase | 2024-09-30 | 13G | Interactive Strength Inc. TRNR | Mitchell P. Kopin | 80,818 4.500% | 80,818 (New Position) | Filing History |
| 2024-11-13 11:15 am Purchase | 2024-09-30 | 13G | Bio-Path Holdings, Inc. BPTH | Mitchell P. Kopin | 194,862 4.990% | 141,162 (+262.87%) | Filing History |
| 2024-11-13 11:14 am Purchase | 2024-09-30 | 13G | Catheter Precision, Inc. VTAK | Mitchell P. Kopin | 181,336 4.990% | 19,331 (+11.93%) | Filing History |
| 2024-11-13 11:14 am Purchase | 2024-09-30 | 13G | Bone Biologics Corporation BBLG | Mitchell P. Kopin | 18,354 4.990% | 1,753 (+10.56%) | Filing History |
| 2024-11-13 11:14 am Purchase | 2024-09-30 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 20,182 4.990% | 13,991 (+226.00%) | Filing History |
| 2024-11-13 11:13 am Sale | 2024-09-30 | 13G | Avinger, Inc. AVGR | Mitchell P. Kopin | 152,118 4.990% | -56,741 (-27.17%) | Filing History |
| 2024-10-03 4:12 pm Purchase | 2024-09-26 | 13G | Theriva Biologics, Inc. TOVX | Mitchell P. Kopin | 118,526 4.990% | 118,526 (New Position) | Filing History |
| 2024-09-12 7:56 pm Purchase | 2024-09-03 | 13G | Catheter Precision, Inc. VTAK | Mitchell P. Kopin | 162,005 9.500% | 162,005 (New Position) | Filing History |
| 2024-09-06 7:45 pm Purchase | 2024-08-29 | 13G | BioCardia, Inc. BCDA | Mitchell P. Kopin | 185,689 4.990% | 185,689 (New Position) | Filing History |
| 2024-09-06 7:43 pm Purchase | 2024-08-29 | 13G | Richtech Robotics Inc. Class B Common Stock RR | Mitchell P. Kopin | 2,585,275 4.990% | 2,585,275 (New Position) | Filing History |
| 2024-08-30 4:11 pm Purchase | 2024-08-22 | 13G | Farmmi, Inc. FAMI | Mitchell P. Kopin | 46,739 4.990% | 46,739 (New Position) | Filing History |
| 2024-08-30 4:11 pm Purchase | 2024-08-23 | 13G | Nuwellis, Inc. NUWE | Mitchell P. Kopin | 98,050 4.990% | 39,162 (+66.50%) | Filing History |
| 2024-08-16 4:03 pm Purchase | 2024-08-09 | 13G | KWESST Micro Systems Inc. KWE | Mitchell P. Kopin | 3,949 4.990% | 3,949 (New Position) | Filing History |
| 2024-08-02 4:12 pm Purchase | 2024-07-24 | 13G | Nuwellis, Inc. NUWE | Mitchell P. Kopin | 58,888 4.990% | 35,602 (+152.89%) | Filing History |
| 2024-07-26 4:18 pm Purchase | 2024-07-18 | 13G | Longeveron Inc. LGVN | Mitchell P. Kopin | 676,229 4.990% | 502,175 (+288.52%) | Filing History |
| 2024-07-26 4:17 pm Purchase | 2024-07-18 | 13G | Silo Pharma, Inc. SILO | Mitchell P. Kopin | 235,527 4.990% | 42,182 (+21.82%) | Filing History |
| 2024-06-21 4:45 pm Purchase | 2024-06-13 | 13G | Avinger, Inc. AVGR | Mitchell P. Kopin | 208,859 9.990% | 208,859 (New Position) | Filing History |
| 2024-06-13 5:08 pm Purchase | 2024-06-04 | 13G | Silo Pharma, Inc. SILO | Mitchell P. Kopin | 193,345 4.990% | 193,345 (New Position) | Filing History |
| 2024-05-31 4:03 pm Purchase | 2024-05-22 | 13G | Banzai International, Inc. BNZI | Mitchell P. Kopin | 25,788 4.990% | 25,788 (New Position) | Filing History |